Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease - Meng, Jiali; Li, Wen; Fu, Wenjing; Zhang, Aihua (Frontiers in Endocrinology, 2025)